Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium

Journal of Cell Science

Volumn 121, Issue 13, 2008, Pages 2197-2207

  Diamond, Michelle E ^a   Sun, Limin ^a,b   Ottaviano, Adam J ^a   Joseph, Mathew J ^a   Munshi, Hidayatullah G ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

EGF; ERK1 2; Motility; N cadherin; Oral cancer; Smad; TGF 1

Indexed keywords

EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE CELL ADHESION MOLECULE; SMAD PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL MIGRATION; CELL MOTILITY; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KERATINOCYTE; MALIGNANT TRANSFORMATION; MOUTH CARCINOMA; MOUTH MUCOSA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; EPITHELIUM; HUMANS; KERATINOCYTES; MITOGEN-ACTIVATED PROTEIN KINASE 3; MOUTH; MOUTH NEOPLASMS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 48049105077     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.021782     Document Type: Article

References (53)

1. Akhurst, R. J. and Derynck, R. (2001). TGF-beta signaling in cancer-a double-edged sword. Trends Cell Biol. 11, S44-S51.
2. Al Moustafa, A. E., Alaoui-Jamali, M. A., Batist, G., Hernandez-Perez, M., Serruya, C., Alpert, L., Black, M. J., Sladek, R. and Foulkes, W. D. (2002). Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 21, 2634-2640.
3. Angst, B. D., Marcozzi, C. and Magee, A. I. (2001). The cadherin superfamily: diversity in form and function. J. Cell Sci. 114, 629-641.
4. Aubin, J., Davy, A. and Soriano, P. (2004). In vivo convergence of BNP and MAPK signaling pathways: impact of differential Smad1 phosphorylation on development and homeostasis. Genes Dev. 18, 1482-1494.
5. Behrens, J., Frixen, U., Schipper, J., Weidner, M. and Birebmeier, W. (1992). Cell adhesion in invasion and metastasis. Semin. Cell Biol. 3, 169-178.
6. Cucoranu, I., Clempus, R., Dikalova, A., Phelan, P. J., Ariyan, S., Dikalov, S. and Sorescu, D. (2005). NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res. 97, 900-907.
7. De Wever, O., Westbroek, W., Verloes, A., Bloemen, N., Bracke, M., Gespach, C., Bruyneel, E. and Mareel, M. (2004). Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-beta or wounding. J. Cell Sci. 117, 4691-4703.
8. Deckers, M., van Dinther, M., Buijs, J., Que, I., Lowik, C., van der Pluijm, G. and ten Dijke, P. (2006). The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res. 66, 2202-2209.
9. Dickson, M. A., Hahn, W. C., Ino, Y., Ronfard, V., Wu, J. Y., Weinberg, R. A., Louis, D. N., Li, F. P. and Rheinwald, J. G. (2000). Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol. 20, 1436-1447.
10. Dunfleld, L. D. and Nachtigal, M. W. (2003). Inhibition of the antiproliferative effect of TGFbeta by EGF in primary human ovarian cancer cells. Oncogene 22, 4745-4751,
11. Forastiere, A., Koch, W., Trotti, A. and Sidransky, D. (2001). Head and neck cancer. N. Engl. J. Med. 345, 1890-1900.
12. Fuentealba, L. C., Eivers, E., Ikeda, A., Hurtado, C, Kuroda, H., Pera, E. M. and De Robertis, E. M. (2007). Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smadl signal. Cell 131, 980-993.
13. Grande, M., Franzen, A., Karlsson, J. O., Ericson, L. E., Heldin, N. E. and Nilsson, M. (2002). Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J. Cell Sci. 115, 4227-4236.
14. Gumbiner, B. M. (2005). Regulation of cadherin-mediated adhesion in morphogenesis. Nat. Rev. Mol. Cell Biol. 6, 622-634.
15. Hazan, R. B., Qiao, P, Keren, R., Badano, I. and Suyama, K. (2004). Cadherin switch in tumor progression. Ann. N. Y. Acad. Sci. 1014, 155-163.
16. Islam, S., Carey, T. E., Wolf, G. T., Wheelock, M. J. and Johnson, K. R. (1996). Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J. Cell Biol. 135, 1643-1654.
17. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T. and Thun, M. J. (2008). Cancer statistics, 2008. CA Cancer J. Clin. 58, 71-96.
18. Juarez, J., Clayman, G., Nakajima, M., Tanabe, K. K., Saya, H., Nicolson, G. L. and Boyd, D. (1993). Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity. Int. J. Cancer 55, 10-18.
19. Knockaert, M., Sapkota, G., Alarcon, C., Massague, J. and Brivanlou, A. H. (2006). Unique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate Smadl to attenuate BNP signaling. Proc. Natl. Acad. Sci. USA 103, 11940-11945.
20. Kretzschmar, M., Doody, J. and Massague, J. (1997). Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 389, 618-622.
21. Kretzschmar, M., Doody, J., Timokhina, I. and Massague, J. (1999). A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev. 13, 804-816.
22. Lengyel, E., Gum, R., Juarez, J., Clayman, G., Seiki, M., Sato, H. and Boyd, D. (1995). Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. Cancer Res. 55, 963-967.
23. Li, G., Satyamoorthy, K. and Herlyn, M. (2001). N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res. 61, 3819-3825.
24. Lin, X., Duan, X., Liang, Y. Y., Su, Y., Wrighton, K. H., Long, J., Hu, M., Davis, C. M., Wang, J., Brunicardi, F. C. et al. (2006). PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell 125, 915-928.
25. Lo, R. S., Wotton, D. and Massague, J. (2001). Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF. EMBO J. 20, 128-136.
26. Lu, S. L., Reh, D., Li, A. G., Woods, J., Corless, C. L., Kulesz-Martin, M. and Wang, X. J. (2004). Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation. Cancer Res. 64, 4405-4410.
27. Maeda, M., Johnson, K. R. and Wheelock, M. J. (2005). Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. J. Cell Sci. 118, 873-887.
28. Maeda, M., Shintani, Y., Wheelock, M. J. and Johnson, K. R. (2006). Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II. J. Biol. Chem. 281, 59-68.
29. Mariotti, A., Perotti, A., Sessa, C. and Ruegg, C. (2007). N-cadherin as a therapeutic target in cancer. Expert Opin. Investig. Drugs 16, 451-465.
30. Massague, J. (2003). Integration of Smad and MAPK pathways: a link and a linker revisited. Genes Dev. 17, 2993-2997.
31. Mukhopadhyay, S., Munshi, H. G., Kambhampati, S., Sassano, A., Platanias, L. C. and Stack, M. S. (2004). Calcium-induced matrix Metalloproteinase 9 gene expression is differentially regulated by ERK1/ 2 and p38 MAPK in oral keratinocytes and oral squamous cell carcinoma. J. Biol. Chem. 279, 33139-33146.
32. Munshi, H, G. and Stack, M. S. (2006). Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev. 25, 45-56.
33. Munshi, H. G., Wu, Y. I., Mukhopadhyay, S., Ottaviano, A. J., Sassano, A., Koblinski, J. E., Platanias, L. C. and Stack, M. S. (2004). Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J. Biol Chem. 279, 39042-39050.
34. Nagata, M., Fujita, H., Ida, H., Hoshina, H., Inoue, T., Seki, Y., Ohnishi, M., Ohyama, T., Shingaki, S., Kaji, M. et al. (2003). Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int. J. Cancer 106, 683-689.
35. Nakao, A., Afrakhte, M., Moren, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawahata, M., Heldin, N. E., Heldin, C. H. et al. (1997), Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389, 632-635.
36. Neville, B. W. and Day, T. A. (2002). Oral cancer and precancerous lesions. CA Cancer J. Clin. 52, 195-215.
37. Nieman, M. T., Prudoff, R. S., Johnson, K. R. and Wheelock, M. J. (1999). N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell Biol. 147, 631-644.
38. Ottaviano, A. J., Son, L., Ananthanarayanan, V. and Munshi, H. G. (2006). Extracellular m atrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1. Cancer Res. 66, 7032-7040.
39. Rheinwald, J. G. and Beckett, M. A. (1981). Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res. 41, 1657-1663.
40. Saha, D., Datta, P. K. and Beauchamp, R. D. (2001). Oncogenic ras represses transforming growth factor-beta/Smad signaling by degrading tumor suppressor Smad4. J. Biol. Chem. 276, 29531-29537.
41. Sapkota, G., Knockaert, M., Alarcon, C., Montalvo, E., Brivanlou, A. H. and Massague, J. (2006). Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways. J. Biol. Chem. 281, 40412-40419.
42. Schilling, S. H., Datto, M. B. and Wang, X. F. (2006). A phosphatase controls the fate of receptor-regulated Smads. Cell 125, 838-840.
43. Schipper, J. H., Frixen, U. H., Behrens, J., Unger, A., Jahnke, K. and Birchmeier, W. (1991), E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res. 51, 6328-6337.
44. Shi, Y. and Massague, J. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685-700.
45. Shintani, Y., Wheelock, M. J. and Johnson, K. R. (2006). Phosphoinositide-3 kinase-Rac1-c-Jun NH2-terminal kinase signaling mediates collagen 1-induced cell scattering and up-regulation of N-cadherin expression in mouse mammary epithelial cells. Mol. Biol. Cell 17, 2963-2975.
46. Sun, Y., Liu, X., Ng-Eaton, E., Lodish, H. F. and Weinberg, R. A. (1999). SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. Proc. Natl. Acad Sci. USA 96, 12442-12447.
47. Suyama, K., Shapiro, I., Guttman, M. and Hazan, P. B. (2002). A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2, 301-314.
48. Tang, B., Vu, M., Booker, T., Santner, S. J., Miller, F. T., Anver, M. R. and Wakefield, L. M. (2003). TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J. Clin. Invest. 112, 1116-1124.
49. Watson-Hurst, K. and Becker, D. (2006). The role of N-cadherin, MCAM and beta3 integrin in melanoma progression, proliferation, migration and invasion. Cancer Biol. Ther. 5, 1375-1382.
50. Wheelock, M. J., Shintani, Y., Maeda, M., Fokumoto, Y. and Johnson, K. R. (2008). Cadherin switching. J. Cell Sci. 121, 727-735.
51. Wrighton, K. H., Willis, D., Long, J., Liu, F., Lin, X. and Feng, X. H. (2006). Small C-terminal domain phosphatases dephosphorylate the regulatory linker regions of Smad2 and Smad3 to enhance transforming growth factor-beta signaling. J. Biol. Chem. 281, 38365-38375.
52. Yang, J., Dai, C. and Liu, Y. (2005). A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J. Am. Soc. Mephrol. 16, 69-78.
53. Zawel, L., Dai, J. L., Buckhaults, P., Zhou, S., Kinzler, K. W., Vogelstein, B. and Kern, S. E. (1998). Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1, 611-617.